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Background: Health policy in the UK and elsewhere is prioritising patient empowerment and patient evaluations of
healthcare. Patient reported outcome measures now take centre-stage in implementing strategies to increase
patient empowerment. This article argues for consideration of patient empowerment itself as a directly measurable
patient reported outcome for chronic conditions, highlights some issues in adopting this approach, and outlines a
research agenda to enable healthcare evaluation on the basis of patient empowerment.
Discussion: Patient empowerment is not a well-defined construct. A range of condition-specific and generic
patient empowerment questionnaires have been developed; each captures a different construct e.g. personal
control, self-efficacy/self-mastery, and each is informed by a different implicit or explicit theoretical framework. This
makes it currently problematic to conduct comparative evaluations of healthcare services on the basis of patient
empowerment. A case study (clinical genetics) is used to (1) illustrate that patient empowerment can be a valued
healthcare outcome, even if patients do not obtain health status benefits, (2) provide a rationale for conducting
work necessary to tighten up the patient empowerment construct (3) provide an exemplar to inform design of
interventions to increase patient empowerment in chronic disease. Such initiatives could be evaluated on the basis
of measurable changes in patient empowerment, if the construct were properly operationalised as a patient
reported outcome measure. To facilitate this, research is needed to develop an appropriate and widely applicable
generic theoretical framework of patient empowerment to inform (re)development of a generic measure. This
research should include developing consensus between patients, clinicians and policymakers about the content
and boundaries of the construct before operationalisation. This article also considers a number of issues for society
and for healthcare providers raised by adopting the patient empowerment paradigm.
Summary: Healthcare policy is driving the need to consider patient empowerment as a measurable patient
outcome from healthcare services. Research is needed to (1) tighten up the construct (2) develop consensus about
what is important to include (3) (re)develop a generic measure of patient empowerment for use in evaluating
healthcare (4) understand if/how people make trade-offs between empowerment and gain in health status.
Keywords: Patient empowerment, Healthcare evaluation, Patient reported outcome measures.Background
Healthcare evaluation relies heavily on measuring health
outcomes. There have been recent calls for healthcare
evaluation to take into account the perceived value of
non-health outcomes such as empowerment, a psycho-
social outcome [1]. The separation of health status from* Correspondence: mcallistermf@cardiff.ac.uk
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reproduction in any medium, provided the orpsychosocial outcomes was first advocated in chronic
disease by Kleinmann in 1988 [2]. Since then, patient
empowerment has gained credibility in healthcare,
reflecting moves away from paternalist models towards
more equitable/collaborative models of clinician-patient
interaction, including shared decision-making [3,4].
Defining patient empowerment
What is patient empowerment? There are many defini-
tions, with most relating in some way to patientshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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over their own health and healthcare, rather than as pas-
sive recipients of healthcare [5-9]. Associated with this,
are ideas of patient compliance and adherence. Compli-
ance refers to the patient submitting to the authority of
their healthcare provider, and arguably belongs within the
paternalist paradigm; adherence refers to the patient vol-
untarily agreeing with a healthcare plan, perhaps devel-
oped through shared decision-making and belongs more
within the empowerment paradigm [10]. Indeed, it has
been argued that patient empowerment offers an alterna-
tive to compliance [5,6]. Most definitions of patient em-
powerment include some conceptualisation of personal
control and self-efficacy/self-mastery [3-9]. The concept
of empowerment could be viewed as another conceptual-
isation of the capability paradigm suggested by Sen and
introduced into healthcare by Coast and colleagues [11-
14]. Most patient empowerment definitions focus on indi-
viduals’ capacity to make decisions about their health (be-
haviour) and to have, or take control over aspects of their
lives that relate to health. Assumptions are that empow-
ered individuals will (a) make more rational healthcare
decisions to maximise their health and wellness (b) de-
crease dependence on healthcare services and (c) ultim-
ately contribute to more cost-effective use of healthcare
resources. However, these consequences remain to be
proven.
Some argue that empowerment may be context and
population specific and that a universal definition may
not be possible [15]. Culture, age and socio-economic
resources undoubtedly influence empowerment, and the
degree to which different social groups can be, and wish
to be, empowered will differ. Others have argued that
empowerment can be considered to be either a process
or an outcome; that patients can be empowered by their
healthcare providers through education, counselling,
patient-centred care, and use of community coaches;
and that patients can empower themselves through self-
education, facilitated by the internet, or by participating
in patient organisations or community activism [16].
Operationalising patient empowerment
The focus of many patient empowerment initiatives has
been to encourage patient self-management of chronic
conditions, although it is not always clear whether em-
powerment is being considered as a process or as an
outcome. In published trials of self-care interventions,
outcomes such as self-reported health, healthcare service
use and patient self-efficacy are measured [7,17,18].
However the ability of the outcome measures used to
capture the patient benefits of these programmes has
been questioned [18]. It is true that those outcomes to-
gether may represent an adequate operationalisation of
self-management, as defined by Lorig and colleagues [8]to include medical or behavioural management, role
management, and emotional management. That opera-
tionalisation of self-management assumes that changes
in self-efficacy should correlate with changes in health
status and clinical outcomes [8]. However, outcomes
such as self-reported health, healthcare service use and
patient self-efficacy fall short of an adequate operatio-
nalisation of broader definitions of patient empower-
ment as outcome, that include the physical, emotional,
cognitive, and spiritual needs of people living with
chronic disease [2-6]. So, some patient benefits, particu-
larly those that belong in the psychosocial realm (emo-
tional, cognitive, social and spiritual needs) may not be
captured.
Despite the absence of a generally accepted definition
of patient empowerment, questionnaires that aim to cap-
ture patient empowerment have been developed in some
areas. However, many of the questionnaires developed
capture limited definitions of patient empowerment.
There are some generic and condition-specific validated
questionnaires that could be classed as patient empower-
ment measures. Examples are shown in Table 1, along
with the constructs that are operationalised in those
measures. All these questionnaires were developed inde-
pendently using different (explicit or implicit) theoretical
frameworks. It is clear that existing measures that cap-
ture (aspects of) patient empowerment are not compar-
able, and many capture limited conceptualisations of
empowerment.
The policy landscape
In the UK, the Coalition Government has reiterated
NHS commitment to patient empowerment with the
publication in 2010 of the NHS White Paper: ‘Equity
and excellence: Liberating the NHS’ [25]. The Health
Minister Andrew Lansley said in his speech to the
House of Commons “Patients will be at the heart of the
new NHS. Our guiding principle will be ‘no decision
about me, without me’. We will bring NHS resources
and NHS decision-making as close to the patient as pos-
sible.” The 2010 White Paper takes forward strategies
developed by Lord Darzi in his review to (1) give
patients more choice and control over their healthcare
and (2) make hospital funding contingent upon perform-
ance against a range of quality measures including
Patient-Reported Outcome Measures (PROMs) [26]. To-
gether, it is claimed that these initiatives will empower
patients.
In the US, self-completion questionnaires are used to
capture aspects of patient satisfaction, e.g. with the de-
gree of involvement patients had with decision-making
about their care. One example of this approach is the
US Consumer Assessment of Healthcare Providers and
Systems (CAHPS) suite of surveys and quality
Table 1 Some examples of validated questionnaires capturing (aspects of) patient empowerment
Measure Conditions-specific
or generic?
Construct operationalised Reference
Patient Enablement
Instrument
Generic Aspects of perceived control over illness Howie et al. 1998 [19]
Patient Activation
Measure
Generic Activation levels (skills, knowledge, and beliefs
needed by patients to self-manage, collaborate
with healthcare providers and maintain their health)
Hibbard et al. 2005 [20]
The Empowerment
Scale
Conditions-specific:
Mental healthcare
Self-efficacy, power-powerlessness, community
activism, righteous anger, and optimism-control
over the future
Rogers et al. 1997 [21],
Diabetes Empowerment
Scale
Conditions-specific: Diabetes Self-efficacy Anderson et al. 2000 [22]
Patient Empowerment
Scale
Conditions-specific:
Cancer
Use of coping resources, an aspect of personal control Bulsara et al. 2006 [23]
Genetic Counselling
Outcome Scale
Conditions-specific: Genetic
conditions
Perceived personal control (cognitive, decisional and
behavioural control), hope and emotional regulation
McAllister et al. 2011 [24]
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isfaction do not capture true outcomes of a healthcare
intervention. A true PROM would measure statistically
significant change in a measurable outcome before and
after an intervention, rather than simply asking about
satisfaction afterwards. PROMs are measures, normally
short self-completion questionnaires, used to capture
aspects of patient health status or health-related quality
of life (HRQL) that come directly from the patient [27].
A key feature of a PROM is that measurements do not
involve attribution of patient states by a healthcare pro-
vider. PROMs are taking an increasingly important role
in healthcare evaluation. PROMs development is also an
important part of the US NIH roadmap, exemplified by
the work of the Patient Reported Outcome Measure-
ment Information Systems (PROMIS) initiative [28].
Discussion
It is clear that health policy in the UK and elsewhere is
prioritising patient empowerment and patient evaluations
of healthcare. This article will argue for consideration of
patient empowerment as a directly measurable patient-
reported outcome (PRO) for chronic conditions. But first,
we will consider some issues that arise in adopting the pa-
tient empowerment perspective.
Arguments against patient empowerment
Are there difficulties in adopting the patient empower-
ment perspective? One counter-argument for patient
empowerment is that the medical establishment wishes
to push forward the empowerment agenda because if
patients take ownership of their own healthcare deci-
sions, then this enables clinicians to avoid responsibility
[29]. However, this argument does not hold water in an
age where the patient’s assessment of their healthcare is
given prominence. Patients are unlikely to be satisfied by
clinicians who shirk responsibility; they can tell thedifference between genuine patient-centred care and
avoidance of responsibility.
A further, perhaps a competing difficulty in adopting
the patient empowerment perspective, is the potential
impact that patient empowerment can have on clinician-
patient relationships. Patient empowerment may require
clinicians to relinquish some control (both informational
and decision-making), and become less compliance-
focused [5]. This would undoubtedly have some status
implications, shifting the balance of power away from
clinicians and towards patients, and this might be very
uncomfortable for some - clinicians and patients alike.
However, this shift in the balance of power is occurring
in our society anyway, facilitated by the internet, by a
service-oriented culture, and by the empowerment of
patient organisations, who are increasingly setting the
agenda in both healthcare and health research. Perhaps
clinicians would do better to fully embrace this cultural
change, by generating evidence that they can contribute
to patient empowerment, rather than resisting it. Indeed,
if clinicians can see evidence that their patients are
benefiting by improved empowerment levels, this might
help them to cope with their own feelings of powerless-
ness to improve patient health status in some
circumstances.
A further counter-argument is that not all people want
to be, or can be empowered at all times. For patients in
acute care, there may be many who would prefer their
doctor to make treatment decisions for them, at least in
the short term. However, for patients with chronic con-
ditions, relying on clinicians to be responsible for main-
taining their health will become less tenable.
Furthermore, if clinicians try to coerce people into mak-
ing lifestyle changes to improve their (future) health,
lifestyle changes that threaten fulfilment of their life
goals, then this may lead to tensions in, and potentially,
breakdown of the healthcare relationship. In practice,
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over the long-term, with only occasional contact with
health services.
Patient empowerment as a directly measurable PRO for
chronic conditions
Use of PROMs in healthcare evaluation is one way in
which healthcare services are empowering patients, as
this approach gives voice to the patients’ evaluations of
the healthcare they have received, and links those eva-
luations to healthcare funding. Another approach could
be to use PROM(s) capturing patient empowerment as
outcome measures in their own right. This approach is
aligned with (a) notions of shared decision-making that
do not (necessarily) privilege health status as the only
valued outcome [1] and (b) conceptualisation of patient
empowerment, not as process, but as a useful, measur-
able health-related psychosocial outcome. Conceivably,
such a construct could be measured using a PROM, en-
abling change over time to be captured. A recent WHO
report called for better tools to measure empowerment
[30]. A generic PROM of patient empowerment that
could be used across a range of instances where patient
empowerment is an explicit goal, such as in the liberated
NHS (e.g. self-care/self-management programmes, per-
sonalised care plans, personal health budgets, shared
decision-making) would enable evaluation of whether
that goal has been achieved.
The George Institute have recently stated that (a) “Pa-
tient empowerment as an operational component of
health reform must . . . have its value quantified” (p. 10)
and (b) “what cannot be measured cannot be changed or
even managed” (p. 11) [31]. We interpret this to mean
that a valid and reliable measure of empowerment would
be useful to evaluate healthcare interventions in a cli-
mate where patient empowerment is to be an integral
part of healthcare reform. A PROM that measures
change over time in empowerment levels would be use-
ful to evaluate health and social care interventions, with
appropriate case mix adjustment. This assertion is sup-
ported by qualitative research suggesting that providing
patients with feelings of control (empowerment) over
their health is highly valued and enables patients to bet-
ter manage their lives, given the limitations imposed by
their condition [32-35]. This approach has been expli-
citly implemented in some areas of healthcare such as
diabetes [36-38] with some promising results.
Some consider patient empowerment to be an aspect
of HRQL [39]. There is a plethora of generic and
condition-specific measures of HRQL, but with general
agreement that the best way to measure these constructs
is by using PROMs. However measures of HRQL do not
provide an adequate measure of patient empowerment
because HRQL is itself an ill-defined construct. HRQLoverlaps with health status and usually is understood to
include one or more of the following dimensions: gen-
eral health (physical and/or mental), functioning (phys-
ical, emotional, cognitive, sexual), social well-being,
coping and adjustment, and existential issues [27]. Self-
reported health status and psychosocial dimensions are
poorly differentiated in HRQL. This makes it difficult to
disentangle health status from psychosocial outcomes
(emotional, cognitive, sexual, social well-being, coping
and adjustment, spiritual) in intervention studies. This is
important because if health status cannot be disen-
tangled from psychosocial outcomes, then trade-offs
cannot be explored between health status and psycho-
social outcomes which in practice, patients may make.
Enabling exploration of such trade-offs may facilitate a
move away from compliance-orientation towards true
patient empowerment, recognising that patients may
also value outcomes other than health status, and poten-
tially make it possible to demonstrate patient benefit
even in situations where health status cannot be
improved or maximised.
A case study
Clinical genetics/genetic counselling services (CGS) pro-
vide a good case study for exploring psychosocial out-
comes in chronic conditions because (a) genetic
conditions are, by their very nature, chronic and life-
long and (b) they can be studied in a health service con-
text largely divorced from a focus on health status. This
is because most genetic conditions cannot be cured, and
currently for most genetic conditions, treatment is lim-
ited to symptom management or screening for compli-
cations. Although many CGS ‘patients’ are themselves
healthy and come seeking a diagnosis in their child, or
seeking information and counselling about their risk of
developing or transmitting a genetic condition, the
‘chronicity’ of their ‘condition’ relates to the life-long and
trans-generational impact of having a genetic condition
in their family. In our work, exploring the best way(s) to
evaluate a CGS, patient empowerment emerged from ex-
tensive qualitative research as a construct summarising
the patient benefits of CGS [32,33]. The emergent model
conceptualises empowerment as a multi-dimensional
construct including
 cognitive control (sense-making - understanding the
condition, why it happened, what help & support is
available - “knowledge is power”)
 decisional control (having some options for
managing the condition/risk and able to make
informed decisions between options),
 behavioural control (able to do something to reduce
harm or improve life for self/child(ren)/at risk
relatives/descendents)
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adjustment)
 hope for the future (for self/relatives/future
descendents).
This exploratory research identified patient empower-
ment as an important patient outcome, valued by
patients and genetics clinicians.
Is there more that can be learned from the CGS case
study? Genetic tests are rarely given routinely in the
genetics clinic, unless a suspected diagnosis of a genetic
condition can only be confirmed or excluded by a gen-
etic test. Because of the eugenic past, modern genetic
counselling endeavours to work within models empha-
sising non-directiveness and shared decision-making
[40]. Goals of genetic counselling include facilitating
informed patient decision-making and adjustment. Com-
pliance is largely irrelevant. In this sense, CGS could be
said to be ‘early adopters’ of the patient empowerment
paradigm and that the rest of medicine is now beginning
to catch up. The approaches and interventions of CGS
could inform the design of interventions in other spe-
cialties aimed at increasing patient empowerment. Inter-
ventions offered by a CGS largely focus on information
provision. This can be information about a genetic diag-
nosis, genetic risk information, information provided by
a genetic test, or information about risk management
options. But genetic counselling also includes facilitating
decision-making about (1) how patients can best use
genetic information given their personal life goals and
values or (2) the appropriateness for the individual pa-
tient of having a predictive or prenatal genetic test -
there may be far-reaching consequences for themselves
and/or their (at risk) relatives. Patients are encouraged
to reflect on multiple possible consequences for their
own life circumstances before they make their decisions.
Different people will make very different decisions, de-
pending on their own life goals and values. The ‘inter-
vention’ facilitates the ability to make decision(s); the
same ‘intervention’ can result in very different actual
decisions, or no decision yet, being reached by different
patients. The important outcome for the patient is the
ability to make those decisions.
Implications for other chronic diseases
We believe that these approaches have implications for
the design and evaluation of patient empowerment
initiatives in other areas of healthcare e.g. self-
management of chronic conditions such as depression,
diabetes and asthma. Self-management programmes can
be designed to empower people affected by chronic con-
ditions to (1) identify, reflect upon and perhaps re-
evaluate their life goals and values (2) understand how
their behaviour influences their health and (3) developthe knowledge, skills, and confidence to make decisions
about their health that best enable them to achieve their
life goals and (4) stay committed when the ‘going gets
tough’.
At present, we know that many patients with chronic
conditions do not comply with what health care profes-
sionals consider optimal management strategies. How-
ever, we do not know whether this is mainly because
patients want to comply, but struggle to and want help,
or because they have priorities other than maximizing
their health status. Previous research suggests that while
some aspects of the decision-making of people with dia-
betes follow a narrow biomedical or strictly instrumental
model of rational decision-making, that aims to
maximize health status, other aspects do not [41]. In-
strumental rationality focuses on outcomes and is con-
cerned with the best means of achieving those
outcomes. In the context of the biomedical model typic-
ally used for health, instrumentally rational choices will
consider the set of all courses of action, a person’s beliefs
about what the outcomes of each course of action is
likely to be, and the person’s subjective valuation and
ranking of those possible outcomes. This simple model
underpins the use of measures of health status and qual-
ity adjusted life years (QALYs) in economic evaluations
to inform health policy and health care decisions. This
simple model can be expanded to incorporate important
constraints. These are first, that people use a set of social
norms to which they subscribe as part of the decision-
making process. These shared rules are fundamental to a
comprehensive model of rational choice. Secondly, indi-
viduals’ ability to find and use all relevant information to
estimate the likely outcomes of all possible courses of
actions is limited (which is necessary for instrumentally
rational choices). As a consequence people treat the
gathering and use of complex information as a cost, and
will accept what appears to be a sub-optimal outcome to
limit the search for further information. Finally, indivi-
duals use judgements rather than explicit calculations of
expected costs and benefits in reaching decisions and
making choices. These judgements incorporate their per-
ceptions about what that choice signals to others as well
as probabilistic, social, moral and ethical uncertainties
about themselves and the world. These broader models
of rationality provide insight into possible reasons for
non-compliance with medically optimal strategies.
Combining this broader definition of rational decision-
making with a patient empowerment approach would
require clinicians to be more open minded and explicit
about what outcomes patients might want, what norms
and constraints the patient feels are important, the
values and uncertainties the patient considers apply to
themselves and the world. Within this broader frame-
work, clinicians can explicitly work with patients to
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to them, and how best to reach those goals. Such an ap-
proach is likely to result in significantly greater positive
participation in healthcare. Perhaps a PROM of patient
empowerment, used alongside measures of self-reported
health status and healthcare service use, could capture
those other valued patient benefits even amongst those
who do not derive dramatic health status benefits, or
may even be used to offset losses in health status. This
raises the question of which outcome we then ‘believe’ if
there are gains in one and losses in the other. It is im-
portant to stress that the two types of outcome are not
necessarily, or even usually, exclusive. Most healthcare
professionals and patients strive to ensure that both out-
comes are achieved. However, where trade-offs are
made, it will be important to understand the trade off,
or relative preferences that people have between health
status and empowerment.
Where do we go from here?
As yet there is no universally accepted generic model or
measure of patient empowerment to enable comparative
evaluations of different services. No two measures of pa-
tient empowerment have operationalised the same theor-
etical construct. Even so, a brief examination of some
available measures confirms areas of convergence around
dimensions of decision-making, control, self-efficacy
(mastery), and self-management of disease (see Table 1).
So a case for developing a generic definition (theoretical
framework) of patient empowerment can be made.
A robust generic theoretical model of patient em-
powerment would form a sound basis for selecting,
developing or re-developing a generic PROM to capture
patient empowerment for use in evaluating healthcare
interventions and policies. But it is premature to choose
or specify a generic model of patient empowerment at
this point. More research is needed to develop an ap-
propriate generic theoretical framework, such as a lit-
erature review to identify existing items/measurement
domains, a theoretical review and classification of items
and consensus development with stakeholders to iden-
tify what is important to include. This approach could
develop a more “formal” or overarching generic con-
struct of patient empowerment. This work should pre-
cede selecting, developing or re-developing a generic
PROM to capture patient empowerment. Further work
to explore relative preferences between health status
and empowerment constructs, using a combination of
qualitative research and discrete choice experiments,
would also be useful.
Another challenge associated with introducing the
measurement of empowerment relates to the current
policy focus of maximising health status [1]. In the UK,
the National Institute for Health and Clinical Excellence(NICE) has a clear rationale behind using health status
and the QALY as the measure of patient benefit. This
rationale is based on the premise that NICE is charged
with providing evidence to inform how best (effectively
and cost effectively) to use the finite ‘health’ care budget.
The result is that the benefits of most technologies and
interventions are valued by changes in health status and
decisions to fund them are informed by evidence on the
cost per additional QALY gained. The case study of
CGS has indicated that not all healthcare interventions
will show an improvement in QALYs. However, if we
‘solve’ this problem by using another measure, such as
empowerment, we then create another problem. We are
now valuing different healthcare interventions using dif-
ferent metrics, which means that another layer of value
judgements must be made to answer: Which should we
prioritise, improvement in health status or improvement
in empowerment? It is possible to view healthcare inter-
ventions as being on a spectrum between those that
purely maximise health (e.g. use of insulin to control
diabetes) and those that purely maximise empowerment
(eg. counselling interventions to improve ability to make
informed health decisions in people living with dia-
betes). However, it is possible to conceive that the latter,
if done well, could contribute significantly to the former,
and indeed this is the basis of most self-management
interventions. This issue indicates the need for more re-
search, which should focus on understanding (a) how
best to maximise both types of outcome for patients
with chronic diseases and (b) any trade-offs that
patients (current and future) make between maximising
health and empowerment, using robust methodologies,
such as discrete choice or best-worse experiments. Re-
search of this kind could facilitate further moves away
from compliance towards adherence and increasing pa-
tient empowerment, for example through patient-
centred processes such as shared decision-making.
Summary
In summary, patient empowerment is firmly on the
health policy agenda in the UK and elsewhere. Patient
evaluations of healthcare have become increasingly im-
portant, and strategies in place to increase patient em-
powerment in the NHS include wider use of PROMs,
personal health budgets and personal health plans.
There is also some evidence to suggest that patient
empowerment may be a valued outcome from health-
care interventions that is related to, but independent
of health status, and furthermore, that patients may
value empowerment as an outcome even if they do
not maximise their health status following a healthcare
intervention. However, there is no widely accepted, ef-
fective method for evaluating whether healthcare strat-
egies and interventions do, in fact, empower patients.
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cept of patient empowerment and ensure patient, clin-
ician and policy consensus on what is important to
include. An appropriately robust theoretical framework
of this kind would enable (re)-development of a robust
generic measure of patient empowerment. The
intention is not to replace existing healthcare evalu-
ation methods, but to supplement them to facilitate
re-orientation of services away from compliance to-
wards increasing patient empowerment.
Abbreviations
CAHPS: Consumer assessment of healthcare providers and systems;
CGS: Clinical genetics/genetic counselling services; HRQL: Health related
quality of life; NHS: National health service; PROM: Patient reported outcome
measure; PROMIS: Patient-reported outcomes measurement information
system; QALY: Quality adjusted life year; UK: United Kingdom; US: United
States of America; WHO: World health organisation.
Competing interests
(1) MM, GD and CT had support from MRC for the submitted work; (2) MM,
GD and CT have no relationships with MRC that might have an interest in
the submitted work in the previous 5 years; (3) their spouses, partners, or
children have no financial relationships that may be relevant to the
submitted work; (4) KP had support from RCUK for the submitted work; (5)
KP has no relationships with RCUK that might have an interest in the
submitted work in the previous 5 years; (6) Her spouse, partner, or children
have no financial relationships with RCUK that may be relevant to the
submitted work; (7) LD, GD and CT had support from HEFCE for the
submitted work; (8) LD, GD and CT have no relationships with HEFCE that
might have an interest in the submitted work in the previous 5 years; (9)
their spouses, partners, or children have no financial relationships that may
be relevant to the submitted work; and (10) MM, KP, LD, GD and CT have no
non-financial interests that may be relevant to the submitted work.
Authors’ contributions
MM (a) conducted and led on publication of the research described in the
case study, in collaboration with the other co-authors, (b) developed the
arguments put forward in this article over the last 8 years, in consultation
with each of the other co-authors, individually and collectively, (c) drafted
the manuscript and co-ordinated input on the manuscript from the co-
authors. GD & CT (a) contributed to design and analysis of the research
described in the case study (b) contributed to developing the arguments
put forward in this article over the last 4 years, in consultation with MM and
the other co-authors and (c) reviewed and revised the manuscript critically
for important intellectual content. KP & LD (a) contributed substantially to
developing the line of argument and the interpretation of data over the last
7 years, and (b) reviewed and revised the manuscript critically for important
intellectual content. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by the NIHR Manchester Biomedical Research
Centre. MM was funded by an MRC Special Training Fellowship in Health
Services Research. KP was funded by an RCUK academic fellowship. GD, KP,
LD & CT are HEFCE funded. The authors accept full responsibility for the
views expressed.
Author details
1Senior Lecturer in Genetic Counselling, Institute of Cancer & Genetics,
Cardiff University, Heath Park, Cardiff CF14 4XN, UK. 2Health Sciences -
Methodology, School of Community-Based Medicine, Manchester Academic
Health Science Centre, The University of Manchester, Jean McFarlane
Building (First Floor), Oxford Road, Manchester M13 9PL, UK. 3The School of
Nursing, Midwifery and Social Work, Manchester Academic Health Science
Centre, The University of Manchester, Jean McFarlane Building (Room
6.314b), Oxford Road, Manchester M13 9PL, UK.Received: 10 February 2012 Accepted: 29 May 2012
Published: 13 June 2012References
1. Payne K, McAllister M, Davies L: Valuing the economic benefits of complex
interventions: when maximising health is not sufficient. Health Econ 2012.
doi:10.1002/hec.2795 [Epub ahead of print].
2. Kleinmann A: The illness narratives: suffering, healing, and the human
condition. US: Basic Books; 1988.
3. Guadagnoli E, Ward P: Patient Participation in Decision-Making. Soc Sci
Med 1998, 47:329–39.
4. Anderson RM, Funnell MM: Patient empowerment: reflections on the
challenge of fostering the adoption of a new paradigm. Pat Ed Counsel
2005, 57:153–7.
5. Aujoulat I, D’Hoore W, Deccache A: Patient empowerment in theory and
practice: Polysemy or cacophony? Pat Ed Counsel 2007, 66:13–20.
6. Aujoulat I, Marcolongo R, Bonadiman L, Deccache A: Reconsidering patient
empowerment in chronic illness: A critique of models of self-efficacy
and bodily control. Soc Sci Med 2008, 66:1228–39.
7. Lorig K, Ritter PL, Villa FJ, Armas J: Community-based peer-led diabetes
self-management: a randomized trial. Diabetes Educ 2009, 35:641–51.
8. Lorig K, Holman H: Self-management education: history, definition,
outcomes, and mechanisms. Ann Behav Med 2003, 26:1–7.
9. Funnell MM, Anderson RM: Patient Empowerment: A Look Back, A Look
Ahead. Diabetes Educ 2003, 29:454–64.
10. National Co-ordinating Centre for NHS Service Delivery and Organisation R
& D (NCCSDO): Concordance, adherence and compliance in medicine
taking. 2005, [www.medslearning.leeds.ac.uk/pages/documents/
useful_docs/76-final-report%5B1%5D.pdf] (accessed 4 April 2012).
11. Sen A: Capability and well-being. Oxford: In The Quality of Life Edited
byNussbaum MC. Clarendon Press; 1993.
12. Coast J, Smith R, Lorgelly P: Welfarism, extra-welfarism and capability: the
spread of ideas in health economics. Soc Sci Med 2008, 67:1190–1198.
13. Coast J, Smith R, Lorgelly P: Should the capability approach be applied in
health economics? Health Economics 2008, 17:667–670.
14. Coast J, Flynn TN, Natarajan L, Sproston K, Lewis J, Louviere JJ, Peters TJ:
Valuing the ICECAP capability index for older people. Soc Sci Med 2008,
67:874–882.
15. Zimmerman MA: Empowerment theory: psychological, organizational
and community levels of analysis. In Handbook of Community Psychology.
Edited by Rapaport J, Seldman E. New York: Plenum; 2000.
16. Holmstrom I, Roing M: The relation between patient-centredness and
patient empowerment: A discussion of concepts. Pat Ed Counsel 2009,
79:167–72.
17. Kennedy A, Reeves D, Bower P, Lee V, Middleton E, Richardson G, Gardner C,
Gately C, Rogers A: The effectiveness and cost-effectiveness of a national lay-
led self-care support programme for patients with long-term conditions: a
pragmatic randomized controlled trial. J Epidemiol Community Health 2007,
61:254–61.
18. Rogers A, Kennedy A, Bower P, Gardner C, Gately C, Lee V, Reeves D, Richardson
G: The United Kingdom Expert Patients Programme: results and implications
from a national evaluation. Med J Aust 2008, 189:S21–S24.
19. Howie JG, Heaney DJ, Maxwell M, Walker JJ: A comparison of a Patient
Enablement Instrument (PEI) against two established satisfaction scales
as outcome measure of primary care consultations. Fam Pract 1998,
15:165–71.
20. Hibbard JH, Mahoney ER, Stockard J, Tusler M: Development and Testing
of a Short Form of the Patient Activation Measure. Health Serv Res 2005,
40:1918–30.
21. Rogers ES, Chamberlain J, Ellison ML, Crean T: A consumer-constructed
scale to measure empowerment among users of mental health services.
Psychiatr Serv 1997, 48:1042–7.
22. Anderson RM, Funnell MM, Fitzgerald JT, Marrero DG: The Diabetes
Empowerment Scale: A measure of psychosocial self-efficacy. Diabetes
Care 2000, 23:739–43.
23. Bulsara C, Styles I, Ward AM, Bulsara M: The Psychometrics of Developing
the Patient Empowerment Scale. J Psychosoc Oncol 2006, 24:1–16.
24. McAllister M, Wood A, Dunn G, Shiloh S, Todd C: The Genetic Counseling
Outcome Scale: A New Patient Reported Outcome Measure for Clinical
Genetics Services. Clinical Genetics 2011, 79:413–424.
McAllister et al. BMC Health Services Research 2012, 12:157 Page 8 of 8
http://www.biomedcentral.com/1472-6963/12/15725. NHS White Paper: Equity and Excellence: Liberating the NHS. 2010,
[www.dh.gov.uk/en/Publicationsandstatistics/Publications/
PublicationsPolicyAndGuidance/DH_117353] (accessed 14 July 2010).
26. Department of Health: High Quality Care for All: NHS Next Stage Review
final report., . [www.dh.gov.uk/en/Publicationsandstatistics/Publications/
PublicationsPolicyAndGuidance/DH_085825] (accessed 1 July 2009).
27. Fayers PM, Machin D: Quality of Life: The assessment, analysis and
interpretation of patient-reported outcomes 2nd edn. Chichester: John Wiley &
Sons Ltd; 2007.
28. Ader DN: Developing the Patient-Reported Outcomes Measurement
Information System (PROMIS). Med Care 2007, 45(Suppl 1).
29. Salmon P, Hall GM: Patient empowerment and control: a psychological
discourse in the service of medicine. Soc Sci Med 2003, 57:1969–80.
30. Wallerstein N: What is the evidence on effectiveness of empowerment to
improve health? Copenhagen: WHO Regional Office for Europe (Health
Evidence Network report; 2006. [http://www.euro.int/Document/E88086.pdf]
(accessed 4 September 2009).
31. The George Institute: Realising the potential of patient empowerment for
tackling chronic disease: Moving from concept to business as usual.
[http://www.bupa.com/media/289194/realising_the_potential_of_patient_
empowerment_-_final.pdf] (accessed 6 January 2012).
32. McAllister M, Payne K, MacLeod R, Nicholls S, Donnai D, Davies S: Patient
Empowerment in Clinical Genetics Services. J Hlth Psychol 2008, 13:
895–905.
33. McAllister M, Dunn G, Todd C: Empowerment: Qualitative Underpinning
of a New Patient Reported Outcome for Clinical Genetics Services. Eur J
Hum Genet 2011, 19:125–30.
34. Wolfe BJ, Sirois FM: Beyond standard quality of life measures: the
subjective experiences of living with inflammatory bowel disease. Qual
Life Res 2008, 17:877–86.
35. Byrne R, Davies L, Morrison AP: Priorities and preferences for the
outcomes of treatment of psychosis: A service user perspective. Psychosis
2010, 2:210–217.
36. George JT, Valdovinos AP, Russell I, Dromgoole P, Lomax S, Torgerson DJ,
Wells T, Thowe JC: Clinical effectiveness of a brief educational
intervention in Type 1 diabetes: results from the BITES (Brief
Intervention in Type 1 diabetes, Education for Self-efficacy) trial. Diabet
Med 2008, 25:1447–53.
37. Lowe J, Linjawi S, Mensch M, James K, Attia J: Flexible eating and flexible
insulin dosing in patients with diabetes: Results of an intensive self-
management course. Diabetes Res Clin Pract 2008, 80:439–43.
38. McCarrier KP, Ralston JD, Hirsch IB, Lewis G, Martin DP, Zimmerman FJ,
Goldberg HI: Web-based collaborative care for type 1 diabetes: a pilot
randomized trial. Diabetes Technol Ther 2009, 11:211–17.
39. Tengland P-A: Empowerment: A goal or a means for health promotion?
Med Hlth Care & Philosophy 2007, 10:197–207.
40. Elwyn G, Gray J, Clarke A: Shared decision making and non-directiveness
in genetic counselling. J Med Genet 2000, 37:135–138.
41. Baker RM: Economic rationality and health and lifestyle choices for
people with diabetes. Social Science & Medicine 2006, 63:2341–2353.
doi:10.1186/1472-6963-12-157
Cite this article as: McAllister et al.: Patient empowerment: The need to
consider it as a measurable patient-reported outcome for chronic
conditions. BMC Health Services Research 2012 12:157.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
